Combination of Sino Biopharmaceutical’s product and VC Tablets for treatment of NCP

On 26 February, Sino Biopharmaceutical Limited (Sino Biopharmaceutical; 01177.HK) announced that according to the information on the website of China Clinical Trial Registry, the clinical research on the efficacy and safety of the combination of Diam...

Vitamins China E-News 202003

www.cnchemicals.com